BackCatabasis Pharmaceuticals Overview

Catabasis Pharmaceuticals Net Tangible Assets

Latest net tangible assets for CATB: $230M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$233.25M

Peer average

Loading

Catabasis Pharmaceuticals Net Tangible Assets History

Loading

Catabasis Pharmaceuticals vs. peers: Net Tangible Assets Comparison

Loading

Catabasis Pharmaceuticals Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Catabasis Pharmaceuticals (CATB) FAQ

As of the most recent data (September 2025), CATB shows a net tangible assets of $230M. Scroll down for historical charts and peer comparison views.

Tracking CATB's net tangible assets over time shows whether Catabasis Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $230M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Catabasis Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $230M) with ownership activity and broader fundamentals.

Catabasis Pharmaceuticals's net tangible assets is $230M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.